Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Haskell

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Cancer|April 1, 1971
Hypercalcemia in chronic granulocytic leukemiaC M Haskell, V T DeVita, G P Canellos
British Journal of Cancer|May 1, 1982
Corynebacterium parvum and metastatic breast cancerC M Haskell, G P Sarna, P Y Liu
Surgical Neurology|September 1, 1975
Metastatic carcinoid presenting as a spinal tumorD B Kirkpatrick, E Dawson, C M Haskell, et al.
Medical and Pediatric Oncology|September 1, 1996
Phase I trial of extracellular adenosine 5'-triphosphate in patients with advanced cancerC M Haskell, M Wong, A Williams, et al.
Cancer Chemotherapy Reports|October 1, 1972
Pharmacologic studies in man with crystallized L-asparaginase (NSC-109229)C M Haskell, G P Canellos, D A Cooney, et al.
Cancer Research|August 1, 1983
Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphyC M Haskell, F Buchegger, M Schreyer, et al.
Current Problems in Cancer|January 1, 1988
Metastasis of unknown originC M Haskell, A J Cochran, S H Barsky, et al.
Annals of Internal Medicine|January 1, 1977
Systemic therapy for metastatic breast cancerC M Haskell, F C Sparks, P R Graze, et al.
The Journal of Laboratory and Clinical Medicine|May 1, 1970
Biocmical and pharmacologic effects of L-asparaginase in manC M Haskell, G P Canellos, D A Cooney, et al.
Cancer|February 15, 1988
Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index--CancerP A Ganz, C M Haskell, R A Figlin, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Cancer|April 1, 1971
Hypercalcemia in chronic granulocytic leukemiaC M Haskell, V T DeVita, G P Canellos
British Journal of Cancer|May 1, 1982
Corynebacterium parvum and metastatic breast cancerC M Haskell, G P Sarna, P Y Liu
Surgical Neurology|September 1, 1975
Metastatic carcinoid presenting as a spinal tumorD B Kirkpatrick, E Dawson, C M Haskell, et al.
Medical and Pediatric Oncology|September 1, 1996
Phase I trial of extracellular adenosine 5'-triphosphate in patients with advanced cancerC M Haskell, M Wong, A Williams, et al.
Cancer Chemotherapy Reports|October 1, 1972
Pharmacologic studies in man with crystallized L-asparaginase (NSC-109229)C M Haskell, G P Canellos, D A Cooney, et al.
Cancer Research|August 1, 1983
Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphyC M Haskell, F Buchegger, M Schreyer, et al.
Current Problems in Cancer|January 1, 1988
Metastasis of unknown originC M Haskell, A J Cochran, S H Barsky, et al.
Annals of Internal Medicine|January 1, 1977
Systemic therapy for metastatic breast cancerC M Haskell, F C Sparks, P R Graze, et al.
The Journal of Laboratory and Clinical Medicine|May 1, 1970
Biocmical and pharmacologic effects of L-asparaginase in manC M Haskell, G P Canellos, D A Cooney, et al.
Cancer|February 15, 1988
Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index--CancerP A Ganz, C M Haskell, R A Figlin, et al.
Pageof 5